Loading insider details...
Beta
Latest Form 4 (Jun 24, 2026): Disposition to Issuer of 45,000 CNTA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 24, 2026 | Centessa Pharmaceuticals plc (CNTA) | Disposition to Issuer | 45,000 | n/a |
| Feb 4, 2026 | Centessa Pharmaceuticals plc (CNTA) | Grant/Award | 45,000 | n/a |
| Feb 4, 2025 | Centessa Pharmaceuticals plc (CNTA) | Grant/Award | 250,000 | n/a |
| Jul 2, 2024 | Centessa Pharmaceuticals plc (CNTA) | Grant/Award | 600,000 | n/a |
| Jun 4, 2024 | Fusion Pharmaceuticals Inc. (FUSN) | Disposition to Issuer | 10,410 | n/a |
| Jan 5, 2024 | Fusion Pharmaceuticals Inc. (FUSN) | Grant/Award | 106,100 | n/a |